LUPANETA PACK
Dead / Cancelled — Cancelled — Section 8 (as of 24 Jan 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85758707
- Registration number
- 4564941
- Mark type
- Stylized text
- Filed
- 19 Oct 2012
- Published for opposition
- 16 Apr 2013
- Registered
- 08 Jul 2014
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, a hormone modifying agent
Owner
- AbbVie Endocrine Inc., North Chicago, IL, US
- AbbVie Endocrine Inc., North Chicago, IL, US
- Abbott Endocrine Inc., Abbott Park, IL, US
- Abbott Endocrine Inc., Abbott Park, IL, US
Prior registrations
Prosecution history
- 24 Jan 2025 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 08 Jul 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Sept 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Sept 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Jul 2020 — TEAS SECTION 8 & 15 RECEIVED
- 08 Jul 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jul 2014 — REGISTERED-PRINCIPAL REGISTER
- 05 Jun 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Jun 2014 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 03 Jun 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jun 2014 — STATEMENT OF USE PROCESSING COMPLETE
- 27 May 2014 — USE AMENDMENT FILED
- 27 May 2014 — TEAS STATEMENT OF USE RECEIVED
- 04 Feb 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED